Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
about
The role of the arginine metabolome in pain: implications for sickle cell diseaseArginase and pulmonary diseasesDysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemiaDevelopmental changes in arginase expression and activity in the lungRed Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia.Pulmonary complications of sickle cell disease.Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria.Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine.Alterations in lung arginine metabolism in lambs with pulmonary hypertension associated with increased pulmonary blood flowPulmonary hypertension in hemolytic disorders: pulmonary vascular disease: the global perspective.Arginase levels and their association with Th17-related cytokines, soluble adhesion molecules (sICAM-1 and sVCAM-1) and hemolysis markers among steady-state sickle cell anemia patients.Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies.Acute chest syndrome: sickle cell disease.Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell diseaseSildenafil therapy in patients with sickle cell disease and pulmonary hypertension.Amino acids, arginase and nitric oxide in vascular health.Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.Protective effect of arginine on oxidative stress in transgenic sickle mouse models.Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress.The Role of Nutrition in Sickle Cell Disease.Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy.Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directionsVasculopathy and pulmonary hypertension in sickle cell disease.Pharmacotherapy in sickle cell disease--state of the art and future prospectsIs arginase a potential drug target in tobacco-induced pulmonary endothelial dysfunction?Effects of a single sickling event on the mechanical fragility of sickle cell trait erythrocytesNitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disordersChronic obstructive pulmonary disease, pollution, pulmonary vascular disease, transplantation, pleural disease, and lung cancer in AJRCCM 2003.Body composition and grip strength are improved in transgenic sickle mice fed a high-protein dietLactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease.Redox-dependent impairment of vascular function in sickle cell disease.An engineered L-arginine sensor of Chlamydia pneumoniae enables arginine-adjustable transcription control in mammalian cells and mice.Arginine metabolism in vascular biology and disease.Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease.Cerebrovascular disease associated with sickle cell pulmonary hypertension.Update in pulmonary hypertension 2005.Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia.Arginine de novo and nitric oxide production in disease states.Therapeutic use of citrulline in cardiovascular disease.
P2860
Q26751338-7BD93145-F5D7-499D-99A6-97364BAFF24FQ28385094-2BE2B40E-7C4A-491D-A323-8FABB62467A6Q28395387-4A8740A0-7DF8-414B-9A0B-AFCFCB745BFAQ28579809-6C5937B0-C8D5-4FE5-B731-8C03D46ACC04Q30275352-98D52AEE-4B8D-4C47-9B51-94F5258F5068Q30515769-65B79552-E683-4DBF-8D44-01021E75A732Q33303521-41A754FC-CFE0-4A40-8314-86C8149DF977Q33803027-AB31BA48-F7C6-4660-87CE-77F3FF97C226Q33889591-495A6924-7500-4A13-9F60-9B091AC8D757Q33899415-8FC102CC-71C3-4626-B483-228AA0D6E1B7Q34013495-AB4F06AC-01DF-47E5-AB4D-AD1A87E36B5DQ34038886-1B42E931-0094-40A8-B5AA-6331019A81F2Q34187526-D2887455-386C-4D19-AE3A-F4FB85C08E38Q34431518-5421F67D-4668-49C5-BD63-9C625BC07B36Q34436782-50021729-25E7-4987-9596-382A52CF1C67Q34489450-188961D1-4F8B-4730-963B-05E4F2E92EF6Q34579250-2DC263D8-44FE-4F4E-AAA1-A97568C8610DQ34589136-FE1DAFA2-A454-4A1A-A225-9681D8362B3AQ34775883-F6C4AF25-E31B-4EC0-9471-C0EB4F5A211CQ34891505-2585E1D3-8B14-4C35-8D6D-C821ABB00D63Q34898802-61FC89F7-D54C-45F8-B48A-BE28A8A8A186Q34992760-8FE992F0-DD04-4ED6-A149-CFBDC993C7B5Q35086394-9D6C8641-A3FC-41EE-867A-4BE77B527A51Q35220342-9FDCF5E5-0D2F-4B75-83E7-92ABA7679A63Q35339312-BBAD5599-2192-4C6E-B065-296E904CD1C5Q35580607-FC1BE06B-D74E-4DB0-BC54-8C45F68BCBC2Q35590733-45554FCD-2F7F-43D1-BBBE-1FF354813623Q35626624-BCD3C1B7-2BBF-4F9B-984F-781FD038F0FCQ35668179-745C6F5F-E845-4C2C-A187-8A4759EE599FQ35849493-C2494007-64EE-4013-9BB2-6ACF392AD3EAQ36088594-719F3EEE-5BBE-4CAE-BB48-8ACE40FDD969Q36274222-81823C42-5D7C-4CC6-943A-9B38300261EAQ36328854-1A70A568-BF43-4E34-8E70-559ED05C8F2AQ36381021-563F8AB8-AB01-4FAF-9328-F27140833244Q36384658-9906F019-B9CF-408B-B119-C684DE149F1BQ36392798-839FFDE6-03E9-4C8F-8B62-976F80D644D3Q36403168-41D8E444-4995-40D1-AE91-F39BBE3CF670Q36419650-82FA76CD-0067-4F63-B3BA-84C9D7FBE6A5Q36454194-EBA87C54-A6D6-4B96-B1BA-2D23EE253346Q36703841-A65703FE-5E2D-4946-8FA2-C884BAF0A293
P2860
Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
@en
Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
@nl
type
label
Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
@en
Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
@nl
prefLabel
Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
@en
Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
@nl
P2093
P2860
P1476
Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
@en
P2093
Claudia R Morris
Diane Kepka-Lenhart
Frans A Kuypers
Jane Van Warmerdam
Lorenzo Machado
Sidney M Morris
Susan Claster
Ward Hagar
P2860
P356
10.1164/RCCM.200208-967OC
P407
P577
2003-03-05T00:00:00Z